about
So depression is an inflammatory disease, but where does the inflammation come from?Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challengesA review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisDepression and sickness behavior are Janus-faced responses to shared inflammatory pathways.Mechanisms underlying neurocognitive dysfunctions in recurrent major depressionMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsThe in vitro immunosuppressive effects of moclobemide in healthy volunteersAlterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugsThe Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune DiseasePutative neuroprotective agents in neuropsychiatric disordersVisualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imagingDepression in cancer: The many biobehavioral pathways driving tumor progression.Relationships of climatic data to immune and hematologic variables in normal human.Haptoglobin polymorphism and schizophrenia: genetic variation on chromosome 16.Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa.Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia.Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients.Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients.Seasonal variation and meteotropism in various self-rated psychological and physiological features of a normal couple.The periodicities in and biometeorological relationships with bed occupancy of an acute psychiatric ward in Antwerp, Belgium.Seasonal and circadian rhythms in suicide in Cagliari, Italy.HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment.Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.Depression and myocardial infarction: relationship between heart and mind.The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contributeDepression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.The immunoregulatory effects of antidepressants.Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome.Research into the specificity of depression after stroke: a review on an unresolved issue.IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway.Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS.Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.
P50
Q21245291-B6D091FF-506F-4918-986E-AA80266DA78EQ26747783-1898129B-372E-4AF8-9391-0A9A8902D26BQ26748778-5797328E-1618-428E-B29D-C8DF732C4A5EQ26823313-C448213C-CC35-43D6-AB13-9C9E7A4CBB89Q26863677-C860F59B-C6FE-4846-ABBD-8224110A8D81Q26998412-C482B423-52B6-4542-A5EC-A2CE805C3D4EQ28141553-469D28C6-6C92-46DC-8195-65E894EE0524Q28273872-D69E9302-9002-4B79-B788-C10151E4292FQ28276657-BA788A97-C8DF-441F-BEDF-7C7B86DB7DEBQ28279830-98D9DDC7-6AD9-43EA-96CD-4348105D00A2Q28303346-213630A4-0DB9-4BAB-AE0D-EA7A29F8D946Q30239759-A00C1A93-6708-4080-BB0A-40CDBCA27992Q30656410-BCEE25E6-E6CA-46D7-A32F-D4A0C5D55C2CQ31015933-11D3F8F6-6604-4023-9844-DFC3CDCB0F5DQ31539063-2106A99C-06EC-408A-9B6A-378CE0E7CBB9Q31657372-AB705B26-744A-4FD0-93E3-4258AB9F731CQ33187740-DF17195A-5F0F-4B29-955D-6A7702045F30Q33205520-C8DBC6C3-06C8-4F90-8910-2892F764650AQ33429931-3587FBE3-851A-4014-BEF1-5F4CBCC03427Q33485203-CEB448AE-6346-4063-88E3-24DDD23C084EQ33654909-88D67DEF-1916-4442-A4AA-23B7D22B5226Q33824172-DB098AC0-8AC2-4805-86DF-89AB55D6C606Q33939777-D380A66F-2FA8-4EC9-9D66-CD05F712A920Q33949053-85B5CE46-F469-47DF-B1B5-255FF2B1EA15Q34025130-8D34AEBA-3D7B-431D-BFC1-9FA487FE0D4AQ34124031-B70B7288-1838-4D52-86C6-958E2F1EEB64Q34141232-2281B082-1B77-4224-A615-EC378931C85FQ34156639-5032C606-DF1A-4BBF-AAAD-F16E8C7D8185Q34241091-C2883107-2E6E-40DD-9CAE-C67BCF5EFCBEQ34242827-6AAC99DE-9B54-4D02-888C-5B95CB73540CQ34263425-2DBF2E4A-4275-44AB-9A47-4B3F3B952756Q34268451-39394E24-CF9C-42EA-BE58-9ED9E7BBA8D7Q34276668-B3306A78-5304-467F-94F5-EEDF63CE47ACQ34333249-8E6FF9D1-6D63-4107-96DF-2AD81357FDA7Q34389771-4A6DADFB-A24E-41BD-8F71-FFC1B7FCA7D6Q34418779-2469368F-921E-4B34-A4E9-C7E84F4D54A5Q34441031-D923AE85-1D65-4B68-B120-B9937C0DBE90Q34464643-A54ABBEF-6626-4A0A-BA55-A79800E587D3Q34474165-948BF28A-5E3E-4898-A5D5-252ABED275B3Q34479982-80880C97-7FE6-467D-9859-2BBD442E58FB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Maes
@ast
Michael Maes
@en
Michael Maes
@es
Michael Maes
@fr
Michael Maes
@nl
Michael Maes
@sl
type
label
Michael Maes
@ast
Michael Maes
@en
Michael Maes
@es
Michael Maes
@fr
Michael Maes
@nl
Michael Maes
@sl
prefLabel
Michael Maes
@ast
Michael Maes
@en
Michael Maes
@es
Michael Maes
@fr
Michael Maes
@nl
Michael Maes
@sl
P106
P1153
7201782377
P21
P31
P496
0000-0002-2012-871X